透視検査装置 - 市場考察、競合情勢、市場予測（2030年）

世界の透視検査装置の市場規模は、2023年に53億米ドルであり、2030年までに73億米ドルに達すると予測され、2024年～2030年の予測期間にCAGRで4.74％の成長が見込まれます。透視検査装置の需要は主に、冠動脈疾患（CAD）、慢性閉塞性肺疾患（COPD）などの慢性疾患の世界的な有病率の上昇、製品上市の増加、疾患の早期発見に関する意識の高まりによって後押しされており、これらが2024年～2030年の予測期間における透視検査装置市場のプラス成長の要因となっています。

透視検査装置の力学

World Heart Report（2023年）が提供した近年のデータによると、2021年に世界全体で5億人超が心血管疾患を抱えて生活しています。

British Heart FoundationのGlobal Heart & Circulatory Diseases Factsheet（2024年）によると、世界中で約2億人がCADとともに生活しています。そのため、心血管疾患の患者の増加に伴い、透視検査装置のような先進の診断オプションに対する需要が高まっています。これらはさまざまな心血管疾患の診断と治療において重要な役割を果たしています。

WHO（2024年）が提供したデータによると、2019年に喘息に罹患した人は2億6,200万人でした。さらに2023年に、世界全体で3億9,200万人のCOPD患者がおり、その4分の3は中低所得国に住んでいます。呼吸器疾患は喘息やCOPDのような合併症を引き起こすことが多いため、先進の診断と治療へのニーズが高まっています。したがって、呼吸器疾患の罹患率の増加は、透視検査装置市場の拡大に直接寄与しています。

さらに、透視検査装置の世界中での製品上市の増加も、市場全体の成長を押し上げると予測されます。例えば2024年1月、Carestream Health, Inc.はDXR-Excel Plusと呼ばれるX線システムを発売しました。DXR-Excelは、透視検査と一般X線検査の両方に対応する2in1システムで、幅広い検査に対応するリアルタイムの画像を提供します。

このため、さまざまな慢性疾患に関連する患者人口が多く、世界的に製品上市が増加していることを考慮すると、透視検査装置市場は2024年～2030年の予測期間に大きく成長することが見込まれます。

しかし、患者だけでなく医療従事者にもリスクをもたらす電離放射線への長時間または反復的な曝露や、その他の代替の装置の利用可能性などは、透視検査装置の成長を制限する可能性のある主な抑制要因です。

透視検査装置セグメント分析

透視検査装置の製品タイプセグメントでは、可動式Cアームシステムカテゴリが2023年に透視検査装置市場で大きな収益シェアを獲得すると推定されました。可動式Cアームシステムの可動性と柔軟性は、特に外来手術を行う診療所、救急室、手術室で一般的になっています。可動式Cアームへのニーズは、高品質な画像の生成を可能にする技術改良の結果、近年徐々に高まっています。また、可動式Cアームのイメージング誘導を頻繁に必要とする低侵襲治療への動向の高まりも、市場シェアの拡大に寄与しています。

さらに、このカテゴリの製品上市も可動式Cアームカテゴリの市場成長を促進すると予測されます。例えば2022年7月、FUJIFILM Holdings Corporationは、病院や外来手術センター（ASC）向けに構築された革新的なハイブリッドCアームと可動式X線ソリューションであるFDR Crossの米国での発売を発表しました。この2つの機能を持ったCアームは、可動性の透視撮影とX線撮影を単一のプラットフォームで提供する初めての製品です。

さらに、可動式Cアーム透視検査装置は、現代の医用画像、特に外科手術やインターベンショナルラジオロジーにおいて、非常に汎用性が高く、必要不可欠なツールです。デジタルフラットパネルディテクターによる先進の画像処理能力を誇り、低線量で優れた画質を実現します。また、ユーザーフレンドリーなタッチスクリーンと直感的なインターフェースを備えており、医療従事者にとって利用しやすいものとなっています。機種によっては、複雑な手技に不可欠な3Dイメージングやナビゲーションシステムを搭載しているものもあります。

したがって、可動式Cアーム透視検査装置カテゴリが提供するさまざまな利点や用途は、このセグメントの成長に寄与し、予測期間の透視検査装置市場全体の成長を促進します。

当レポートでは、世界の透視検査装置市場について調査分析し、各地域の市場規模と予測、過去3年間の製品/技術開発、各セグメントの業績と見通しなどの情報を提供しています。

目次

第1章 透視検査装置市場レポートのイントロダクション

第2章 透視検査装置市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 透視検査装置市場の主な要因の分析

• 透視検査装置市場の促進要因
• 透視検査装置市場の抑制要因と課題
• 透視検査装置市場の機会

第6章 透視検査装置市場のポーターのファイブフォース分析

第7章 透視検査装置市場の評価

• 製品タイプ別
  • 固定式Cアームシステム
  • 可動式Cアームシステム
• 用途別
  • 心臓
  • 呼吸器
  • 腫瘍
  • その他
• エンドユーザー別
  • 病院、診療所
  • 診断センター
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 透視検査装置市場の企業と製品のプロファイル

• Siemens Healthcare Private Limited
• GE HealthCare
• Koninklijke Philips N.V
• Shimadzu Corporation
• Ziehm Imaging GmbH
• Carestream Health, Inc.
• Orthoscan, Inc.
• CANON MEDICAL SYSTEMS CORPORATION
• FUJIFILM Holdings Corporation
• Allengers
• DMS Group
• Villa Sistemi Medicali Spa
• Eurocolumbus srl
• Genoray Co., Ltd.
• Bimedis
• Omega Medical Imaging, LLC
• Hologic, Inc
• Adani Systems Inc.
• Agfa-Gevaert Group
• Scanray Technologies Limited

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Fluoroscopy Equipment in Global (2021-2030)
• Table 3: Fluoroscopy Equipment in Global by Product Type (2021-2030)
• Table 4: Fluoroscopy Equipment in Global by Application (2021-2030)
• Table 5: Fluoroscopy Equipment in Global by End-User (2021-2030)
• Table 6: Fluoroscopy Equipment in Global by Geography (2021-2030)
• Table 7: Fluoroscopy Equipment in North America (2021-2030)
• Table 8: Fluoroscopy Equipment in the United States (2021-2030)
• Table 9: Fluoroscopy Equipment in Canada (2021-2030)
• Table 10: Fluoroscopy Equipment in Mexico (2021-2030)
• Table 11: Fluoroscopy Equipment in Europe (2021-2030)
• Table 12: Fluoroscopy Equipment in France (2021-2030)
• Table 13: Fluoroscopy Equipment in Germany (2021-2030)
• Table 14: Fluoroscopy Equipment in the United Kingdom (2021-2030)
• Table 15: Fluoroscopy Equipment in Italy (2021-2030)
• Table 16: Fluoroscopy Equipment in Spain (2021-2030)
• Table 17: Fluoroscopy Equipment in the Rest of Europe (2021-2030)
• Table 18: Fluoroscopy Equipment in Asia-Pacific (2021-2030)
• Table 19: Fluoroscopy Equipment in China (2021-2030)
• Table 20: Fluoroscopy Equipment in Japan (2021-2030)
• Table 21: Fluoroscopy Equipment in India (2021-2030)
• Table 22: Fluoroscopy Equipment in Australia (2021-2030)
• Table 23: Fluoroscopy Equipment in South Korea (2021-2030)
• Table 24: Fluoroscopy Equipment in Rest of Asia-Pacific (2021-2030)
• Table 25: Fluoroscopy Equipment in the Rest of the World (2021-2030)
• Table 26: Fluoroscopy Equipment in the Middle East (2021-2030)
• Table 27: Fluoroscopy Equipment in Africa (2021-2030)
• Table 28: Fluoroscopy Equipment in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Fluoroscopy Equipment in Global (2021-2030)
• Figure 3: Fluoroscopy Equipment in Global by Product Type (2021-2030)
• Figure 4: Fluoroscopy Equipment in Global by Application (2021-2030)
• Figure 5: Fluoroscopy Equipment in Global by End-User (2021-2030)
• Figure 6: Fluoroscopy Equipment in Global by Geography (2021-2030)
• Figure 7: Fluoroscopy Equipment in North America (2021-2030)
• Figure 8: Fluoroscopy Equipment in the United States (2021-2030)
• Figure 9: Fluoroscopy Equipment in Canada (2021-2030)
• Figure 10: Fluoroscopy Equipment in Mexico (2021-2030)
• Figure 11: Fluoroscopy Equipment in Europe (2021-2030)
• Figure 12: Fluoroscopy Equipment in France (2021-2030)
• Figure 13: Fluoroscopy Equipment in Germany (2021-2030)
• Figure 14: Fluoroscopy Equipment in United Kingdom (2021-2030)
• Figure 15: Fluoroscopy Equipment in Italy (2021-2030)
• Figure 16: Fluoroscopy Equipment in Spain (2021-2030)
• Figure 17: Fluoroscopy Equipment in the Rest of Europe (2021-2030)
• Figure 18: Fluoroscopy Equipment in Asia-Pacific (2021-2030)
• Figure 19: Fluoroscopy Equipment in China (2021-2030)
• Figure 20: Fluoroscopy Equipment in Japan (2021-2030)
• Figure 21: Fluoroscopy Equipment in India (2021-2030)
• Figure 22: Fluoroscopy Equipment in Australia (2021-2030)
• Figure 23: Fluoroscopy Equipment in South Korea (2021-2030)
• Figure 24: Fluoroscopy Equipment in Rest of Asia-Pacific (2021-2030)
• Figure 25: Fluoroscopy Equipment in the Rest of the World (2021-2030)
• Figure 26: Fluoroscopy Equipment in the Middle East (2021-2030)
• Figure 27: Fluoroscopy Equipment in Africa (2021-2030)
• Figure 28: Fluoroscopy Equipment in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Fluoroscopy Equipment By Product Type (Fixed C-Arm Systems And Mobile C-Arm Systems), Application (Cardiology, Respiratory, Oncology, And Others), End-User (Hospitals And Clinics, Diagnostic Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic diseases globally, increase in product launches, and increasing awareness about early disease detection

The fluoroscopy equipment device market was valued at USD 5.30 billion in 2023, growing at a CAGR of 4.74% during the forecast period from 2024 to 2030 to reach USD 7.30 billion by 2030. The demand for fluoroscopy equipment is primarily being boosted by the rising prevalence of chronic diseases such as Coronary Artery Disease (CAD), Chronic Obstructive Pulmonary Disease (COPD), among others globally, increase in product launches, and rising awareness about early disease detection are some factors contributing to the positive growth of the fluoroscopy equipment market during the forecast period from 2024 to 2030.

Fluoroscopy Equipment Dynamics:

As per the recent data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally.

According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people were living with CAD around the world. Therefore, with rise in the cases of cardiovascular disorders, there's a growing demand for advanced diagnostic options like fluoroscopy equipment. These play a crucial role in the diagnosis and treatment of various cardiovascular conditions.

According to the data provided by WHO (2024), in 2019 that there were 262 million people affected by asthma. Additionally in 2023, there were 392 million people living with COPD globally, with three quarters of them living in low and middle income countries. As, respiratory diseases often lead to complications such as asthma and COPD, it spurs the critical need for advanced diagnostic and treatment options. Therefore, the growing incidence of respiratory diseases directly contributes to the expanding market for fluoroscopy equipment.

Moreover, the increased number of product launches in the fluoroscopy equipment globally is also expected to boost the overall market growth. For instance, in January 2024, Carestream Health, Inc. launched an X-ray system called DXR-Excel Plus. It is a two-in-one system for both fluoroscopy and general radiology that delivers real-time, images for a wide range of examinations.

Therefore, considering the large patient pool associated with different chronic disorders, and the rising product launches globally, the market for fluoroscopy equipment is expected to grow significantly during the given forecast period from 2024 to 2030.

However, prolonged or repeated exposure to ionizing radiations that raise risks for patients as well as for healthcare professionals, availability of other alternative equipments, among others are some of the key constraints that may limit the growth of the fluoroscopy equipment.

Fluoroscopy Equipment Segment Analysis:

Fluoroscopy Equipment by Product type (Fixed C-Arm Systems and Mobile C-Arm Systems), Application (Cardiology, Respiratory, Oncology, and Others), End-User (Hospitals and Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest Of The World)

In the product type segment of the fluoroscopy equipment, the mobile C-arm system category was estimated to amass a significant revenue share in the fluoroscopy equipment market in 2023. Portability and flexibility of mobile C-arm systems have become more common, particularly in ambulatory surgical clinics, emergency rooms, and operating rooms. The need for mobile C-arms has been rising gradually in recent years as a result of technological improvements that enabled them to produce high-quality images. Their increasing market share has also been aided by the growing trend towards minimally invasive treatments, which frequently need mobile C-arm imaging guidance.

Additionally, product launches in this category are also expected to drive the market growth for the mobile c-arms category. For example, In July 2022, FUJIFILM Holdings Corporation announced US launch of the FDR Cross, an innovative hybrid c-arm and portable x-ray solution built for hospitals and ambulatory surgery centers (ASC). The dual-function c-arm was the first of its kind to offer portable fluoroscopic and radiographic imaging on a single platform.

Moreover, Mobile C-arm fluoroscope equipment is a highly versatile and essential tool in contemporary medical imaging, particularly in surgery and interventional radiology. They boast advanced imaging capabilities with digital flat-panel detectors that deliver superior image quality with lower radiation doses. They also feature user-friendly touch screens and intuitive interfaces, making them accessible to medical professionals. Some models include 3D imaging and navigation systems, which are crucial for complex procedures.

Therefore, the various advantages and applications provided by the mobile C arm fluoroscopy equipment category will contribute to the growth of the segment, thereby driving the growth of the overall fluoroscopy equipment market during the forecast period.

North America Is Expected To Dominate The Overall Fluoroscopy Equipment:

North America is expected to account for the highest proportion of the fluoroscopy equipment market in 2023, out of all regions due to several key factors. The high incidence of chronic diseases, including cardiovascular conditions and respiratory illnesses, increases the demand for accurate diagnostic and treatment tools. Additionally, the efficient regulatory frameworks that ensure the safety and efficacy of medical devices further encourage the adoption of fluoroscopy equipment in clinical settings, also the increased product launches in the US. Together, these factors drive the expansion of the fluoroscopy equipment market in North America.

According to the latest updated data provided by the Centers for Disease Control and Prevention (CDC) (2024), it was stated that 805,000 people in the US had a heart attack every year, and about 1 out of 5 are silent heart attacks.

Additionally, the latest data provided by the National Institute of Health (2023), stated that 20.5 million people in the US were living with CAD. Fluoroscopy is vital for visualizing the heart and blood vessels in real-time, identifying blockages, abnormalities, and reduced blood flow for early intervention. It guides procedures like angioplasty and stent placement with precision, ensuring optimal outcomes in managing heart conditions. Therefore, the high incidence of heart attacks and the widespread prevalence of coronary artery disease may siginificantly increase the demand for fluoroscopy equipment during the forecast period.

According to the latest updated data by the American Lung Association, in 2023 approximately 11.7 million people in the US were living with chronic respiratory disorders, which over time made it harder for patients to breathe.

Furthermore, as per the data provided by CDC (2023), in 2021, approximately 14.2 million people in the US had chronic obstructive pulmonary disease (COPD). Fluoroscopy's real-time imaging helps identify respiratory system issues like blockages. During procedures like bronchoscopy, it guides physicians to navigate airways precisely, visualize problem areas, and collect diagnostic samples.

Thus the increase in various respiratory disorders requires precise diagnosis and treatment, the importance of fluoroscopy equipment in respiratory care is increasingly recognized, thus driving the demand for fluoroscopy equipment.

Furthermore, increased product launches in North America also plays a major role in the increasing market for fluoroscopy equipment. For instance, in June 2021, FUJIFILM Holdings Corporation, Inc., announced the launch of Persona RF PREMIUM's in the US market. The Persona RF PREMIUM is a unique radiography and fluoroscopy system that offered real-time imaging for the skeletal, digestive, urinary, respiratory, and reproductive systems, as well as for particular organs like the kidneys, heart, and lung.

Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North American fluoroscopy equipment market growth during the forecast period from 2024 to 2030.

Fluoroscopy Equipment Key Players:

Some of the key market players operating in the fluoroscopy equipment include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V, Shimadzu Corporation, Ziehm Imaging GmbH, Carestream Health, Inc., Orthoscan, Inc., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Allengers, DMS Group, Villa Sistemi Medicali Spa, Eurocolumbus srl, Genoray Co., Ltd., Bimedis, Omega Medical Imaging, LLC., Hologic, Inc, Adani Systems Inc, Agfa-Gevaert Group, Scanray Technologies Limited, and others.

Recent Developmental Activities In The Fluoroscopy Equipment:

• In November 2023, The Norwegian Vestre Viken Health Trust and Philips announced that AI-enabled clinical care had been implemented to help radiologists improve patient care. The clinical applications platform powered by AI from Philips will expedite the diagnosis of bone fractures.
• In September 2021, Siemens Healthcare Private Limited launched Luminos Impulse that offered high efficiency for digital fluoroscopy and radiography. It included seamless imaging chain, comprehensive dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.

Key Takeaways From The Fluoroscopy Equipment Report Study

• Market size analysis for current fluoroscopy equipment size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global fluoroscopy equipment.
• Various opportunities available for the other competitors in the fluoroscopy equipment space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current fluoroscopy equipment scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for fluoroscopy equipment growth in the coming future?

Target Audience Who Can Be Benefited From The Fluoroscopy Equipment Report Study

• Fluoroscopy equipment product providers
• Research organizations and consulting companies
• Fluoroscopy equipment-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in fluoroscopy equipment
• Various end-users who want to know more about the fluoroscopy equipment and the latest technological developments in the fluoroscopy equipment

Frequently Asked Questions For The Fluoroscopy Equipment:

1. What are fluoroscopy equipment?

Fluoroscopy equipment is a medical imaging technology that uses X-rays to produce moving, real-time images of a patient's interior tissues. It is made up of an X-ray source, a display monitor, a collimator, and a fluorescent screen or image intensifier.

2. What is the market for fluoroscopy equipment?

The fluoroscopy equipment device market was valued at USD 5.30 billion in 2023, growing at a CAGR of 4.74% during the forecast period from 2024 to 2030 to reach USD 7.30 billion by 2030.

3. What are the drivers for the fluoroscopy equipment?

The fluoroscopy equipment is slated to witness prosperity owing to factors such as the rising prevalence of chronic diseases such as Coronary Artery Disease (CAD) and Chronic Obstructive Pulmonary Disease (COPD) globally, an increase in product launches, and the rising awareness about early disease detection, among others thus contributing to the positive growth of the fluoroscopy equipment market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the fluoroscopy equipment?

Some of the key market players operating in the fluoroscopy equipment include Siemens Healthcare Private Limited, GE HealthCare, Koninklijke Philips N.V, Shimadzu Corporation, Ziehm Imaging GmbH, Carestream Health, Inc., Orthoscan, Inc., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Allengers, DMS Group, Villa Sistemi Medicali Spa, Eurocolumbus srl, Genoray Co., Ltd., Bimedis, Omega Medical Imaging, LLC., Hologic, Inc, Adani Systems Inc, Agfa-Gevaert Group, Scanray Technologies Limited, and others.

5. Which region has the highest share in the fluoroscopy equipment?

North America is expected to dominate the overall Fluoroscopy Equipment during the forecast period from 2024 to 2030. This is owing to the high incidence of chronic diseases, including cardiovascular conditions and respiratory illnesses, increasing the demand for accurate diagnostic and treatment tools. Additionally, the efficient regulatory frameworks that ensure the safety and efficacy of medical devices, and the increased product launches further encourage the adoption of fluoroscopy equipment in clinical settings in the US. Together, these factors are expected to drive the expansion of the fluoroscopy equipment market in North America.

Table of Contents

1. Fluoroscopy Equipment Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Fluoroscopy Equipment Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Fluoroscopy Equipment Market Key Factors Analysis

• 5.1. Fluoroscopy Equipment Market Drivers
  • 5.1.1. The rising prevalence of chronic diseases globally
  • 5.1.2. Increase in product launches
  • 5.1.3. Increasing awareness about early disease detection
• 5.2. Fluoroscopy Equipment Market Restraints and Challenges
  • 5.2.1. Prolonged or repeated exposure to ionizing radiation that raises risks for patients and healthcare professionals
• 5.3. Fluoroscopy Equipment Market Opportunities
  • 5.3.1. Integration with AI to facilitate procedure optimization

6. Fluoroscopy Equipment Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Fluoroscopy Equipment Market Assessment

• 7.1. By Product Type
  • 7.1.1. Fixed C-Arm Systems
  • 7.1.2. Mobile C-Arm Systems
• 7.2. By Application
  • 7.2.1. Cardiology
  • 7.2.2. Respiratory
  • 7.2.3. Oncology
  • 7.2.4. Others
• 7.3. By End-User
  • 7.3.1. Hospitals and Clinics
  • 7.3.2. Diagnostic Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.1.2. Canada Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Fluoroscopy Equipment Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.2. Germany Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.4. Italy Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.5. Spain Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Fluoroscopy Equipment Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.2. Japan Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.3. India Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.4. Australia Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Fluoroscopy Equipment Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.4.2. Africa Fluoroscopy Equipment Size in USD million (2021-2030)
    • 7.4.4.3. South America Fluoroscopy Equipment Size in USD million (2021-2030)

8. Fluoroscopy Equipment Market Company and Product Profiles

• 8.1. Siemens Healthcare Private Limited
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. GE HealthCare
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Koninklijke Philips N.V
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Shimadzu Corporation
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Ziehm Imaging GmbH
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Carestream Health, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Orthoscan, Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. CANON MEDICAL SYSTEMS CORPORATION
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. FUJIFILM Holdings Corporation
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Allengers
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. DMS Group
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Villa Sistemi Medicali Spa
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Eurocolumbus srl
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Genoray Co., Ltd.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Bimedis
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Omega Medical Imaging, LLC
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Hologic, Inc
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Adani Systems Inc.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Agfa-Gevaert Group
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Scanray Technologies Limited
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us